vs

Side-by-side financial comparison of PARK AEROSPACE CORP (PKE) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.

PARK AEROSPACE CORP is the larger business by last-quarter revenue ($17.3M vs $11.2M, roughly 1.5× Verastem, Inc.). PARK AEROSPACE CORP runs the higher net margin — 17.0% vs -876.3%, a 893.4% gap on every dollar of revenue.

Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

PKE vs VSTM — Head-to-Head

Bigger by revenue
PKE
PKE
1.5× larger
PKE
$17.3M
$11.2M
VSTM
Higher net margin
PKE
PKE
893.4% more per $
PKE
17.0%
-876.3%
VSTM

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
PKE
PKE
VSTM
VSTM
Revenue
$17.3M
$11.2M
Net Profit
$3.0M
$-98.5M
Gross Margin
34.1%
Operating Margin
21.0%
-362.2%
Net Margin
17.0%
-876.3%
Revenue YoY
20.3%
Net Profit YoY
87.1%
-311.1%
EPS (diluted)
$0.15
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PKE
PKE
VSTM
VSTM
Q4 25
$17.3M
Q3 25
$16.4M
$11.2M
Q2 25
$15.4M
$2.1M
Q1 25
$16.9M
Q4 24
$14.4M
Q3 24
$16.7M
$0
Q2 24
$14.0M
$10.0M
Q1 24
$16.3M
Net Profit
PKE
PKE
VSTM
VSTM
Q4 25
$3.0M
Q3 25
$2.4M
$-98.5M
Q2 25
$2.1M
$-25.9M
Q1 25
$1.2M
Q4 24
$1.6M
Q3 24
$2.1M
$-24.0M
Q2 24
$993.0K
$-8.3M
Q1 24
$2.7M
Gross Margin
PKE
PKE
VSTM
VSTM
Q4 25
34.1%
Q3 25
31.2%
Q2 25
30.6%
Q1 25
29.3%
Q4 24
26.6%
Q3 24
28.5%
Q2 24
29.3%
Q1 24
27.3%
Operating Margin
PKE
PKE
VSTM
VSTM
Q4 25
21.0%
Q3 25
17.4%
-362.2%
Q2 25
15.7%
-2047.9%
Q1 25
16.8%
Q4 24
12.8%
Q3 24
15.7%
Q2 24
14.9%
-182.8%
Q1 24
15.7%
Net Margin
PKE
PKE
VSTM
VSTM
Q4 25
17.0%
Q3 25
14.7%
-876.3%
Q2 25
13.5%
-1213.6%
Q1 25
7.4%
Q4 24
10.9%
Q3 24
12.4%
Q2 24
7.1%
-82.6%
Q1 24
16.3%
EPS (diluted)
PKE
PKE
VSTM
VSTM
Q4 25
$0.15
Q3 25
$0.12
$-1.35
Q2 25
$0.10
$-0.62
Q1 25
$0.06
Q4 24
$0.08
Q3 24
$0.10
$-0.60
Q2 24
$0.05
$-0.31
Q1 24
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PKE
PKE
VSTM
VSTM
Cash + ST InvestmentsLiquidity on hand
$63.6M
$137.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$106.6M
$-15.5M
Total Assets
$118.1M
$176.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PKE
PKE
VSTM
VSTM
Q4 25
$63.6M
Q3 25
$61.6M
$137.7M
Q2 25
$65.6M
$164.3M
Q1 25
$68.8M
Q4 24
$70.0M
Q3 24
$72.0M
$113.2M
Q2 24
$74.4M
$83.4M
Q1 24
$77.2M
Total Debt
PKE
PKE
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$40.5M
Q2 24
$40.3M
Q1 24
Stockholders' Equity
PKE
PKE
VSTM
VSTM
Q4 25
$106.6M
Q3 25
$105.8M
$-15.5M
Q2 25
$105.0M
$36.1M
Q1 25
$107.2M
Q4 24
$107.4M
Q3 24
$110.3M
$11.1M
Q2 24
$111.7M
$18.9M
Q1 24
$112.9M
Total Assets
PKE
PKE
VSTM
VSTM
Q4 25
$118.1M
Q3 25
$116.4M
$176.9M
Q2 25
$120.7M
$196.3M
Q1 25
$122.1M
Q4 24
$124.2M
Q3 24
$125.1M
$126.4M
Q2 24
$129.4M
$105.7M
Q1 24
$132.3M
Debt / Equity
PKE
PKE
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.66×
Q2 24
2.14×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PKE
PKE
VSTM
VSTM
Operating Cash FlowLast quarter
$5.1M
$-36.2M
Free Cash FlowOCF − Capex
$4.3M
FCF MarginFCF / Revenue
24.6%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$3.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PKE
PKE
VSTM
VSTM
Q4 25
$5.1M
Q3 25
$-2.1M
$-36.2M
Q2 25
$1.6M
$-32.7M
Q1 25
$969.0K
Q4 24
$2.7M
Q3 24
$1.4M
$-23.8M
Q2 24
$-423.0K
$-27.6M
Q1 24
$5.3M
Free Cash Flow
PKE
PKE
VSTM
VSTM
Q4 25
$4.3M
Q3 25
$-2.3M
Q2 25
$1.1M
Q1 25
$338.0K
Q4 24
$2.7M
Q3 24
$1.3M
Q2 24
$-435.0K
$-27.6M
Q1 24
$5.1M
FCF Margin
PKE
PKE
VSTM
VSTM
Q4 25
24.6%
Q3 25
-14.0%
Q2 25
7.2%
Q1 25
2.0%
Q4 24
18.6%
Q3 24
7.5%
Q2 24
-3.1%
-275.8%
Q1 24
31.4%
Capex Intensity
PKE
PKE
VSTM
VSTM
Q4 25
4.8%
Q3 25
1.1%
Q2 25
3.1%
Q1 25
3.7%
Q4 24
0.4%
Q3 24
1.2%
Q2 24
0.1%
0.1%
Q1 24
1.0%
Cash Conversion
PKE
PKE
VSTM
VSTM
Q4 25
1.73×
Q3 25
-0.88×
Q2 25
0.76×
Q1 25
0.78×
Q4 24
1.73×
Q3 24
0.70×
Q2 24
-0.43×
Q1 24
1.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PKE
PKE

North America$16.8M97%
Other$546.0K3%

VSTM
VSTM

Segment breakdown not available.

Related Comparisons